← All organizations
Highest phase reached
Phase 3
First clinical trial
Mar 1, 2002Last known activity
Nov 30, 2025
Timeline
1990s
- Jan 1, 1996
Van Andel Research Institute— Founded
Drugs by trial phase (16 distinct, 11 trials)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (6 own, 0 via acquisition)
Phase 1 (6 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Indications
Studied for
- Adenocarcinoma
- Breast Neoplasms
- Carcinoma
- Carcinoma, Ductal
- Carcinoma, Hepatocellular
- Cholangiocarcinoma
- Gallbladder Neoplasms
- Leukemia
- Leukemia, Myelomonocytic, Chronic
- Leukemia, Myelomonocytic, Juvenile
- Lung Neoplasms
- Medulloblastoma
- Myelodysplastic Syndromes
- Neuroblastoma
- Pancreatic Neoplasms
- Triple Negative Breast Neoplasms
Recent trials (11)
- NCT07157735CollaboratorPhase 2Nov 30, 2025
- NCT07207057CollaboratorPhase 3Sep 12, 2025
- NCT04741945CollaboratorPhase 2Aug 31, 2021
- NCT04134884CollaboratorPhase 1Dec 31, 2019
- NCT03999723CollaboratorPhase 2Aug 26, 2019
- NCT03257761CollaboratorPhase 1Feb 7, 2018
- NCT03682029CollaboratorN/ANov 21, 2017
- NCT03220477CollaboratorPhase 1Aug 4, 2017
- NCT01483820CollaboratorPhase 1/Phase 2Dec 1, 2011
- NCT01473251CollaboratorN/ANov 1, 2011
- NCT00202800CollaboratorPhase 2Mar 1, 2002
Details
- Founded
- Grand Rapids, MI, US Jan 1, 1996
- Last known activity
- Nov 30, 2025